New Topical Treatment for Erectile Dysfunction Cleared for Sale Over-the-Counter in the US
The First of Its Kind
Pharmaceutical company Futura Medical has announced that its topical erectile dysfunction treatment gel, Eroxon, has been cleared by the US Food and Drug Administration (FDA) for over-the-counter sale in the United States. According to the company, this makes Eroxon the first topical erectile dysfunction treatment available without a prescription.
Meeting High Standards
Eroxon has been granted a “de novo” classification by the FDA, signifying that it is a new type of product that meets the organization’s standards for efficacy and safety. Futura Medical CEO James Barder expressed his pleasure in meeting these standards in a press statement released on Monday.
Availability and Pricing
Eroxon is already available in Belgium and the UK, where a four-pack of the product costs around £24.99 or about $31.22 in the United States. Pricing for Eroxon’s US launch is dependent upon the partner who will be distributing the product, and the launch date is currently predicted to be around 2025.
How Does Eroxon Work?
Application and Results
Eroxon comes in a single-dose tube and should be applied to the head of the penis for 15 seconds before sexual intercourse. According to marketing material for the product, users can expect an erection within 10 minutes of application, with the effects lasting long enough for satisfactory sexual activity in 65% of cases. Erections should disappear naturally.
Factors That Contribute to Erectile Dysfunction
In the United States, approximately 30 million men suffer from erectile dysfunction. Difficulties maintaining a firm erection can be caused or worsened by a variety of factors, including type 2 diabetes, side effects from medications, anxiety or depression, substance abuse, smoking, and being overweight.
The Future of Erectile Dysfunction Treatment
The Promise of Eroxon
Eroxon’s status as the first topical erectile dysfunction treatment available without a prescription marks a significant step in the treatment of a widespread medical issue. As more and more men seek out remedies for erectile dysfunction, Eroxon’s accessibility and ease of use may make it a preferred choice for those who do not wish to take oral medications.
Further Research and Development
As with any new medical product or treatment, more research and development is needed to determine the long-term efficacy and safety of Eroxon. Nevertheless, the product’s success in the UK and Belgium has set the stage for future innovation in the treatment of erectile dysfunction.